Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|March 16, 2026
Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of Single-arm StudiesShanghai Liu, Xinyu Hu, Ruizhan Tong, et al.
International Journal of Cancer|June 9, 2026
Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination TrialsXuanwei Zhang, Hui Wang, Weiyan Tang, et al.
Molecular Carcinogenesis|July 22, 2017
PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosisTuotuo Gong, Shuyu Zheng, Shan Huang, et al.
Oncology Reports|February 3, 2018
Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cellsShenbo Fu, Long Jin, Tuotuo Gong, et al.
Oncotarget|August 5, 2016
HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivoRuxing Xi, Shupei Pan, Xin Chen, et al.
Journal for Immunotherapy of Cancer|February 10, 2026
CD4<sup>+</sup> T cells facilitate the RT-induced abscopal effect by promoting antigen cross-presentation to CD8<sup>+</sup> T cells at unirradiated tumor sitesXi Rao, Kateryna Onyshchenko, Meidan Wang, et al.
Oncotargets and Therapy|March 19, 2015
Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinomaRuxing Xi, Xiaozhi Zhang, Xin Chen, et al.
Thoracic Cancer|July 31, 2023
Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapyXianyan Chen, Xiaoman Tian, Xuanwei Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2023
Pure Organic AIE Nanoscintillator for X-ray Mediated Type I and Type II Photodynamic TherapyYuewen Yu, Lisha Xiang, Xuanwei Zhang, et al.
Translational Lung Cancer Research|June 10, 2024
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancerLaduona Wang, Yijun Wu, Kai Kang, et al.
Pageof 4